| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/11/2002 | CA2169629C Human erythropoietin receptor fragment and antibodies thereto |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2095861C Structural proteins from artificial genes |
| 06/11/2002 | CA2088478C Cloning and expression of a rhoptry associated protein of p. falciparum |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2073186C Gene deleted in colorectal cancer in humans |
| 06/11/2002 | CA2061167C Process for the purification of a highly glycolsylated protein |
| 06/11/2002 | CA1341367C Enhanced production of proteins by cell culture |
| 06/11/2002 | CA1341366C Molecular clones of the genome of htlv-iii |
| 06/06/2002 | WO2002045201A2 Non-cytolytic soluble factor from activated-expanded cd4 cells |
| 06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | WO2002044722A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 06/06/2002 | WO2002044718A2 S.aureus protein staau r2, gene encoding it and uses thereof |
| 06/06/2002 | WO2002044424A1 Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancer |
| 06/06/2002 | WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | WO2002044415A1 Method for screening of dna libraries and generation of recombinant dna constructs |
| 06/06/2002 | WO2002044409A2 Substrate linked directed evolution (slide) |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044390A2 Floral development genes |
| 06/06/2002 | WO2002044389A1 Novel transcriptional factor enhancing the resistance of plants to osmotic stress |
| 06/06/2002 | WO2002044388A1 Production of heterologous polypeptides in yeast |
| 06/06/2002 | WO2002044386A2 Targeted regulation of gene expression |
| 06/06/2002 | WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | WO2002044383A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 06/06/2002 | WO2002044382A1 Cytokine-like proteins |
| 06/06/2002 | WO2002044381A2 Human vno receptor (r1) |
| 06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044378A2 Wnt signalling assay, methods and uses thereof |
| 06/06/2002 | WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | WO2002044376A2 Modulation of gene expression using insulator binding proteins |
| 06/06/2002 | WO2002044375A2 Compositions and methods for diagnosing or treating psoriasis |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044373A2 Adipocyte complement related protein zacrp12 |
| 06/06/2002 | WO2002044372A2 Nucleotide and protein sequence of helios 3 and methods of use |
| 06/06/2002 | WO2002044371A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044369A1 Novel human chloride channel |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044365A1 Mammalian nuclear receptor cofactor cf9 and methods of use |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044363A1 Methods for modulating apoptotic cell death |
| 06/06/2002 | WO2002044362A1 Method of screening remedy for diabetes |
| 06/06/2002 | WO2002044354A2 Molecules of the card-related protein family and uses thereof |
| 06/06/2002 | WO2002044348A2 Method for purifying adenoviruses |
| 06/06/2002 | WO2002044345A1 Methods and products for manipulating hematopoietic stem cells |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044340A2 Novel nucleic acids and polypeptides |
| 06/06/2002 | WO2002044337A2 Wooden leg gene, promoter and uses thereof |
| 06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | WO2002044334A2 Recombinant rsv virus expression systems and vaccines |
| 06/06/2002 | WO2002044333A2 Polynucleotides useful for modulating transcription |
| 06/06/2002 | WO2002044332A2 Prostate polynucleotides and uses |
| 06/06/2002 | WO2002044331A2 Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer |
| 06/06/2002 | WO2002044330A2 Crystal structure of rotavirus nsp4 peptide |
| 06/06/2002 | WO2002044215A2 Hybrid antibodies |
| 06/06/2002 | WO2002044214A1 Methods for the synthesis of a modified hemoglobin solution |
| 06/06/2002 | WO2002044212A2 Human g-protein coupled receptor and uses thereof |
| 06/06/2002 | WO2002044211A2 Endozepine like protein, polynucleotide encoding them and methods of using the same |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044208A1 Methods of screening for agonists and antagonists of the hneaa81 receptor |
| 06/06/2002 | WO2002044207A1 Immunotherapeutic methods and molecules |
| 06/06/2002 | WO2002044206A2 Membrane fusion proteins derived from reovirus |
| 06/06/2002 | WO2002044205A2 Peptides from ag85 of mycobacterium and uses thereof |
| 06/06/2002 | WO2002044204A2 Cell-free assembly of lentiviral capsids |
| 06/06/2002 | WO2002044203A2 Production of recombinant bmp-2 |
| 06/06/2002 | WO2002044202A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 06/06/2002 | WO2002044199A2 Neurotoxins with enhanced target specificity |
| 06/06/2002 | WO2002044198A2 Haplotypes of the slc1a4 gene |
| 06/06/2002 | WO2002044197A2 Cytokine receptor binding peptides |
| 06/06/2002 | WO2002043759A2 Method and composition for modulating bone growth |
| 06/06/2002 | WO2002043757A2 Medicament for preventing or treating tumors caused by human papilloma virus type 18 |
| 06/06/2002 | WO2002043756A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 06/06/2002 | WO2002043754A1 Proteins binding hcv and their medical, diagnostic and purification use |
| 06/06/2002 | WO2002043749A1 Inducing expression of heat shock proteins |
| 06/06/2002 | WO2002043746A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2002 | WO2002043658A2 Fcrn-based therapeutics for the treatment of auto-immune disorders |
| 06/06/2002 | WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies |
| 06/06/2002 | WO2002028895A3 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 06/06/2002 | WO2002024737A8 Nucleotide sequences which code for the dps gene of c. glutamicum |
| 06/06/2002 | WO2002022784A3 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g |
| 06/06/2002 | WO2002022674A3 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Parietaria judaica |
| 06/06/2002 | WO2002022652A3 Haplotypes of the slc18a2 gene |
| 06/06/2002 | WO2002020792A8 Efflux protein dep33 of corynebacterium glutamicum |
| 06/06/2002 | WO2002020555A3 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 06/06/2002 | WO2002018437A3 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 06/06/2002 | WO2002018428A3 Sequences which code for the sige gene of corynebacterium glutamicum |
| 06/06/2002 | WO2002018420A3 Cofactors of the pregnane x receptor and methods of use |
| 06/06/2002 | WO2002014473A3 Animals expressing exogenous igf-i in their milk |
| 06/06/2002 | WO2002013606A3 Improved insecticidal bacteria, and methods for making and using them |
| 06/06/2002 | WO2002008384A3 Novel glutamate transporters |
| 06/06/2002 | WO2002005843A3 Human rrp sequences and methods of use |
| 06/06/2002 | WO2002002606A3 Immunisation against chlamydia pneumoniae |
| 06/06/2002 | WO2001098456A3 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 06/06/2002 | WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 06/06/2002 | WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 06/06/2002 | WO2001094385A8 Human hm74-like g protein coupled receptor |